Flywings Simulator Training Centre IPO is open from December 5 to December 9, priced between ₹181 and ₹191 per share. Flywings Simulator Training Centre Limited operates in the field of Aviation ...

Apple has followed up its in-person Manufacturing Academy with a new program that sees its small- and medium-sized business training go online. Back in July 2025, Apple announced its first Apple ...

The course covers the need for and history of Pharmaceutical GMP as well as the key GMP requirements at the various parts of a pharmaceutical manufacturing site, from goods-in to despatch of the ...

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Apple announced on Monday it has expanded its ...

Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. The drugmaker has selected Huntsville, Alabama, as the site of a $6 ...

Nanoform Finland Plc | Inside Information | December 16, 2025 at 07:00:00 EET Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced new ...

Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity Bioworks™ Financing led by 3i, LP ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On ...

Aequs IPO: The initial public offering (IPO) of Aequs Ltd enters its second day of bidding today, 4 December 2025. Aequs IPO got oversubscribed on the first day of the subscription period with two ...

The success of efforts to turn Phoenix into a dominant center of semiconductor manufacturing may hinge on efforts to train local workers. A gowning area at Arizona State University’s student-operated ...

Psyence Biomedical Ltd. ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that ...

Financing led by 3i, LP includes $16M debt financing for the purchase of assets and up to $75M in preferred convertible equity available for therapeutics commercialization and corporate growth ...